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Abstract
Background: Periprosthetic bacterial infections represent one of the most challenging orthopaedic complications that often
require implant removal and surgical debridement and carry high social and economical costs. Diabetes is one of the most
relevant risk factors of implant-related infection and its clinical occurrence is growing worldwide. The aim of the present
study was to test a model of implant-related infection in the diabetic mouse, with a view to allow further investigation on
the relative efficacy of prevention and treatment options in diabetic and non-diabetic individuals.
Methodology: A cohort of diabetic NOD/ShiLtJ mice was compared with non-diabetic CD1 mice as an in vivo model of S.
aureus orthopaedic infection of bone and soft tissues after femur intramedullary pin implantation. We tested control and
infected groups with 16103 colony-forming units of S. aureus ATCC 25923 strain injected in the implant site. At 4 weeks
post-inoculation, host response to infection, microbial biofilm formation, and bone damage were assessed by traditional
diagnostic parameters (bacterial culture, C-reactive protein and white blood cell count), histological analysis and imaging
techniques (micro computed tomography and scanning electron microscopy).
Results: Unlike the controls and the CD1 mice, all the diabetic mice challenged with a single inoculum of S. aureus displayed
severe osteomyelitic changes around the implant.
Conclusions: Our findings demonstrate for the first time that the diabetic mouse can be successfully used in a model of
orthopaedic implant-related infection. Furthermore, the same bacteria inoculum induced periprosthetic infection in all the
diabetic mice but not in the controls. This animal model of implant-related infection in diabetes may be a useful tool to test
in vivo treatments in diabetic and non-diabetic individuals.
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Introduction
Post-operative bacterial infection is among the most challenging
orthopaedic complications associated with primary (1–4%) and
revision (.20%) prosthetic [1–3] and implant surgery [4]. Septic
complications are the first and the third reason for knee and hip
joint prosthesis failure, respectively, in the Unites States [5]. These
severe complications frequently lead to implant removal and/or
extensive surgical debridement and carry a high social and
economical burden [6–8].
Diabetes mellitus is one of the most relevant risk factors for post-
operative orthopaedic infections [9,10]. Studies investigating the
differences in infection response in diabetic and non-diabetic
patients cite innate immune system defects and increased
adherence of microorganisms to cells as the prime reason causes
for the impaired ability of diabetics to fight infection [11,12]. In
diabetic patients receiving a prosthetic implant, the rate of
infection is more than 10% higher than in non-diabetic subjects
[13] and type 1 diabetes has been reported to be associated with a
higher risk of post-operative complications after hip or knee
arthroplasty as compared to type 2 diabetes [14]. In addition,
diabetes induced neuropathy and vasculopathy play an additional
role in the development of infections and relative high mortality
[9].
As the world population ages, the incidence of diabetes mellitus
and orthopaedic prosthetic surgery will increase in the coming
years [15].
The most common pathogens of implant-related infections are
opportunistic microorganisms, including methicillin-susceptible or
resistant Staphylococcus epidermidis and aureus (80%), Streptococcus spp.
and Gram-negative bacteria (20%). Typically, these bacteria are
able to adhere to one another, forming a microbial assembling
embedded in an extracellular matrix, the ‘‘biofilm’’, that leads to
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persistent local (osteomyelitis) and/or systemic infections and
retains a multifactorial tolerance to host immune cells and
antibiotic treatments [16–18].
Although infections in diabetic patients are frequently polymi-
crobial, S. aureus and epidermidis account for the pathogens most
often the cause of post-surgical infections, with many strains
resistant to antibiotics, making the treatment of infections very
problematic [17]. Patients with type 1 diabetes show more
frequent colonization of the skin by S. aureus than non-diabetic
and non-insulin dependent diabetic individuals [19]. Various
diabetic animal models have been developed to study the
pathogenesis of diabetes and its complications and to test novel
diabetic treatments before clinical use [8]. The most common
model for type 1 diabetes is the non-obese diabetic mouse (NOD/
ShiLtJ) which spontaneously develops diabetes closely resembling
the pathophysiology of the condition in humans [20]. In
orthopaedics, however, diabetic animal models have been used
only to investigate delayed bone fracture healing [21] or diabetic
foot infections [10].
In this study, we compared the diabetic NOD/ShiLtJ mouse
with the non-diabetic CD1 mouse as an in vivo model of S. aureus
orthopaedic infection of bone and soft tissues after femur
intramedullary pin implantation. To do this, we used conventional
diagnostic parameters (bacterial culture, C-reactive protein and
white blood count), histological findings and advanced imaging
technologies in orthopaedic (micro-computed tomography [micro-
CT] and scanning electron microscopy [SEM]) [22,23] to assess
host response to infection, microbial biofilm formation and bone
damage in the healthy and the diabetic mice.
Materials and Methods
Ethics Statement
The whole study was approved by the Mario Negri Institute for
Pharmacological Research (IRFMN) Animal Care and Use
Committee (IACUC) (Permit N. 43_2013-B) which includes "ad
hoc" members for ethical issues. Animals and their care were
handled in compliance with institutional guidelines as defined in
national (Law 116/92, Authorization n.19/2008-A issued March
6, 2008, by the Italian Ministry of Health) and international laws
and policies (EEC Council Directive 86/609, OJ L 358. 1,
December 12, 1987; Standards for the Care and Use of
Laboratory Animals - UCLA, U. S. National Research Council,
Statement of Compliance A5023-01, November 6, 1998). The
animals were housed at the Institute’s Animal Care Facilities that
meet international standards; they were regularly checked by a
certified veterinarian responsible for health monitoring, animal
welfare supervision, experimental protocols and procedure revi-
sion.
Experimental design
The diabetic mouse (NOD/ShiLtJ) model of staphylococcal
orthopaedic implant-related infection was compared to the non-
diabetic mouse (CD1) model of implant-related infection and to
controls.
The mice were randomly assigned to the one of four
experimental groups (n = 8 animals in each group):
Group I CD1 mice + 3 ml Phosphate Buffered Saline (control/
PBS)
Group II CD1 mice + S. aureus 103 Colony Forming Unit
(CFU)/3 ml (infected/SA)
Group III NOD/ShiLtJ mice + 3 ml PBS (control/PBS)
Group IV NOD/ShiLtJ mice + S. aureus 103 CFU/3 ml
(infected/SA)
Table 1 reports the allocation of animals per group and the
relative analysis.
Preparation of S. aureus for inoculation into the joint
space
S. aureus strain ATCC 25923 was used in this study. Bacteria
were cultured at 37uC overnight onto Mannitol Salt Agar
(BioMerieux, France). To prepare the inoculum, a selected colony
was inoculated into Brain Heart Infusion Broth (BioMerieux) and
incubated for 16 h at 37uC. The bacterial suspension was then
washed twice and the obtained pellet was suspended in PBS to
obtain a 0.5 McFarland turbidity (equal to about 16108 CFU/
mL), and further diluted to obtain a bacterial concentration of
about 3.36105 CFU/mL. The bacterial suspension was then
serially diluted with sterile saline solution and counts were
performed to check the bacterial inocula for the experiments.
The bacterial suspension was used within 2 h and stored on ice
until use.
In vivo surgical procedures
Sixteen female CD1 14 week old mice (mean body weight
37.5 g) (Charles River, Italy) and sixteen female NOD/ShiLtJ type
I diabetic 14 week old mice (mean body weight 23.5 g) (Jackson
Laboratory) were used for the experiments. Blood glucose levels in
the NOD/ShiLtJ mice were tested directly by Charles River to
guarantee the diabetic status of the animals on delivery. The mice
were maintained under specific pathogen-free conditions and fed
with autoclaved food and water provided ad libitum. All pre-
surgical and surgical procedures on the animals were performed
under a laminar flow hood.
The mice were anesthetized via inhalation of isoflurane (2%)
(Fig. 1 A) and maintained with an intraperitoneal injection of
ketamine chloride 80 mg/kg (Imalgene, Merial, Italy) and
medetomidine hydrochloride 1 mg/kg (Domitor, Pfizer, Italy).
All efforts were made to minimize suffering. After skin preparation
Table 1. Allocation of animals per group and investigations.
INVESTIGATIONS NUMBER OF ANIMALS
1 2 3 4 5 6 7 8
Blood analysis x x x x x x x x
Micro-CT x x x x x
Histology x x x
Microbiology x x x x
SEM x
doi:10.1371/journal.pone.0067628.t001
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by shaving and disinfection with alcohol and povidone iodine (Fig.
1 B), an incision was performed over the right knee (Fig. 1 C). The
distal right femur was accessed through a medial parapatellar
arthrotomy. After identifying the intercondylar notch, a 25-gauge
needle (Ø 0.5 mm), used as implant, was inserted retrograde into
the medullary canal of the femur to a depth of 7–10 mm and then
cut so that 1 mm protruded into the joint space (Fig. 1 D). This
surgical technique has been described elsewhere [24]. The metallic
implant was left in the medullar canal of the femur for 28 days. In
this study, we chose an intramedullary implant approach since it
reproduces the serious infections seen in patients after total joint
replacement. In the infected groups (II and IV), a volume of 3 mL
of the bacterial suspension, corresponding to an inoculum of about
16103 CFU/mouse, according to the literature [24,25], was
injected into the joint space on the protruding edge of the implant
(Fig. 1 E) and the solution was allowed to spread throughout the
medullary canal. In the sham-inoculated control groups (I and III),
sterile PBS was injected as described above. The quadriceps-
patellar complex was repositioned to the midline, and the incision
was sutured with interrupted stitches (Ethilon 4-0, Ethicon, US)
(Fig. 1 F). Micro-CT of the contralateral limb was used as the
untreated healthy control for all animals.
Immediately after surgery, all animals received a one-shot
injection of carprofen 5 mg/kg SC (Rimadyl, Pfizer, Italy) and
ceftriaxone 60 mg/kg IM (Rocephin, Roche, Italy). Atipamezole
1 mg/kg (Antisedan, Pfizer, Italy) was administered subcutane-
ously to recover the animals from general anesthesia. The animals
were then housed in separate cages under a heating lamp and
monitored until the effects of anesthesia had worn off. About 24 h
later, the animals were grouped four per cage, monitored daily for
general status and welfare, and checked weekly to record data on
body weight, clinical signs of infection, lameness, weight bearing,
swelling, wound healing, pain and suffering. Pain was controlled
with buprenorphine (0.1 mg/kg SC).
After 4 weeks, the mice were euthanized by CO2 inhalation to
perform the investigations.
Surgical dissection was performed under a laminar flow hood
and in sterile conditions; the soft tissues were inspected for gross
appearance (signs of inflammation and infection), then stripped off,
and the femurs were disarticulated at the hip joint to be removed.
Blood collection and analysis
Blood samples for total white blood cells (WBC) count and C-
Reactive Protein (CRP) (n = 32) determination were collected from
the facial vein on day 0 and directly from the left ventricle
immediately after sacrifice (day 28).
Facial vein blood draws were done with an 18G needle
puncturing the skin slightly dorsally (1–2 mm) to the mandible
angle to a shallow depth of approximately 1–2 mm and a volume
of 200 ml of blood was collected by allowing the blood to drop
directly into centrifuge tubes.
Figure 1. Mouse surgical procedures. Anesthesia chamber with isoflurane inhalation (A); skin preparation (B); skin incision over the right knee (C);
introduction of a 25-gauge needle retrograde into the femoral medullary canal (D); inoculation of 3 ml of S. aureus (E) and closure of the surgical site
with interrupted sutures (F).
doi:10.1371/journal.pone.0067628.g001
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Heart blood was collected through a 21G needle inserted into
the abdomen near the sternum and directed towards the heart;
500 ml of blood were obtained from the left ventricle.
The blood was immediately transferred to centrifuge tubes
containing the appropriate anticoagulants for cell counting or into
empty tubes for measuring serum CRP. EDTA anticoagulated
blood samples for total WBC were processed on an automatic cell
counter for human use (Sysmex XT-1800, Dasit). To measure
CRP, the sera were serially diluted and the protein was measured
with a latex immunoassay (CRP Vario, Abbott Diagnostics)
according to the manufacturer’s instructions.
Micro-CT imaging and data analysis
To evaluate periosteal, cortical and endosseous reaction, and
the development of deformities, osteomyelitis and osteolysis,
micro-CT analysis (n = 5 per group) were performed.
Immediately after sacrifice, the femurs were removed, placed
into a culture dish and scanned with an Explore Locus micro-CT
scanner (GE Healthcare, London, Ontario, Canada), without
using contrast agents.
A micro-CT lower-resolution (Bin-2) protocol was performed
using 80 kV voltage, 450 mA current with 300 msec exposure time
per projection and 720 projections over 360u for a total scan time
of approximately 24 minutes. The isotropic resolution of this
protocol is 45 mm. The radiation dose was estimated to be 0.60
Gy. The reconstructed 3D images were viewed and analyzed using
the Micro View image viewer (version 2.1.2; GE Healthcare) for
the analysis of osteomyelitis. The images from each sample were
binarized at identical thresholds to allow for unbiased identifica-
tion of bone damage and osteolysis.
An image analysis approach was designed specifically to
measure the outer bone volume of the femur and evaluate
anatomical changes. Briefly, a volume of interest (VOI) around the
hind limb was designed and the bone structure was separated from
air and soft tissues with a global thresholding procedure. After
defining the optimal threshold for bone, an isosurface volume
rendering function (a ray cast method that renders the surfaces of
objects of similar density and hides the remaining materials) was
applied to visualize and determine the presence and extent of
infection-induced osteolytic lesions and bone reactions.
Bone mineral density (BMD) was measured with micro-CT,
which was calibrated during the first scan of each session using a
phantom made of an epoxy-based resin that mimics hydroxyap-
atite and contains water and air inclusion. The phantom was
placed in the field of view of the scanned specimen. Before volume
reconstruction, the data were calibrated against the phantom using
the reconstruction software. The BMD (mg/cc) was measured on
the bone volume designed on the femoral bone by the Micro View
bone analysis tool.
Histological analysis
Femoral specimens (n = 3 per group) were dissected and fixed in
10% formalin overnight.
The bones were decalcified in Mielodec (Bio-Optica, Milan,
Italy) for 4 days, dehydrated in 70% (vol/vol) ethanol, embedded
in paraffin and cut into 5 mm sagittal sections. The slides were
dried, deparaffinized and stained with haematoxylin and eosin
(H&E) as per standard protocol to assess morphology and with
Gram staining for bacterial examination.
Photomicrographs were captured using an Olympus IX71 light
microscope and an Olympus XC10 camera.
The severity of inflammation and infection was evaluated on the
basis of periosteal reaction, cortical bone and medullary canal
alterations, according to the modified grading score proposed by
Petty et al. [26] (Table 2).
Microbiological analysis
To evaluate bacterial bone colonization, bacteria were recov-
ered from the bone samples (n = 4 per group) taken on day 28
from all animals under aseptic conditions. The specimens were
placed in sterile tubes and weighed, then cut into small pieces,
transferred to a sterile tube containing 1 mL of normal sterile
saline and sonicated in an ultrasound bath (VWR, Italy) for 5 min
at a frequency of 30 kHz and a power output of 300 W, at room
temperature. After vortexing for 5 min, aliquots of the sonicated
fluid were seeded on Mueller-Hinton agar (BioMerieux) and
incubated for 16 h at 37uC. After incubation, colonies resembling
S. aureus were counted and the (Log CFU)/g bone was determined.
In particular, colonies were assessed for Gram stain and catalase
tests. Gram-positive catalase positive cocci were subcultured onto
Mannitol Salt Agar and checked for coagulase production.
Mannitol positive coagulase positive colonies were identified as
S. aureus and counted. The detection limit was 1.3 (Log CFU)/g of
bone. A single microbiologist blinded to the specimen groups
conducted all microbiological analyses.
SEM analysis
After explantation, one sample per group was fixed in 2.5%
paraformaldehyde and 2.5% glutaraldehyde in 0.1 M Na-Caco-
dylate buffer (pH 7.4). After fixation, the samples were rinsed with
Na-Cacodylate buffer and fixed for 1h in OsO4 (1% in Na-
Cacodylate buffer), then samples dehydrated in ethanol, mounted
on aluminum stubs and sputter-coated with gold using a
SEMPREP 2 Sputter Coater (Nanotech Ltd). Observations were
performed with a LEO 1400 EVO Scanning Electron Microscope
(Zeiss) mixing secondary (SE) and backscattered electrons (BSE)
detectors. Images were acquired at 10 kV at a working distance of
7 mm.
Table 2. Histological classification by modified Petty et al. (1985).
Periosteum Cortex Medullary canal
0 Absence of reaction Small Haversian canals, subperiosteal resorption, absence of
polymorpho-nucleated leukocytes
Absence of inflammatory cells or foci of intact polymorpho-
nucleated leukocytes
1 Laminated with 1–2 layers Occasional polymorph nucleated leukocytes in Haversian canalsDiffuse polymorpho-nucleated leukocytes
2 Sunburst type Focally enlarged Haversian canals filled with granulation tissue,
fragmented polymorpho-nucleated leukocytes and osteoclasts
Diffuse intact and fragmented polymorpho-nucleated
leukocytes, several micro abscesses
3 Florid, sunburst type Subperiosteal, endosteal and intracortical resorption,
fragmented polymorpho-nucleated leukocytes and micro
abscesses, many osteoclasts
Several micro- and macroabscesses in diffuse polymorpho-
nucleated leukocytes
doi:10.1371/journal.pone.0067628.t002
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Statistical analysis
Comparisons between groups were analyzed with one-way
analysis of variance (ANOVA) (Instat 2.0; Graphpad Software,
San Diego, CA). Comparisons between groups and time points
were analyzed with two-way ANOVA. When significant differ-
ences were detected, post hoc comparisons of means were
performed using Bonferroni’s procedure. All data are expressed
as means 6 standard error (SEM). Values of P,0.05 were
considered statistically significant.
Results
Gross appearance and clinical data
The NOD/ShiLtJ mice developed early diabetes with moderate
glycosuria and non-fasting plasma glucose levels . 130 mg/dl at
14 weeks of age.
The CD1 mice inoculated with 103 CFU S. aureus (group II)
showed mild lameness 7 days after implantation which promptly
resolved the week after, whereas the NOD/ShiLtJ mice inoculated
with 103 CFU S. aureus (group IV) developed persistent lameness,
restricted movement or avoided weight bearing and vacillated in
use of the treated limb. Also noted were severe signs of infection,
with erythema and swelling of soft tissues, knee and hip joint
abscesses, fistulae, sometimes purulent exudates on compression,
and loss of proprioception starting the first week post-inoculation.
Two animals with severe signs of infection received additional
treatment with buprenorphine for pain control. These observa-
tions were confirmed on dissection and gross examination after
sacrifice 4 weeks after implantation. Group IV showed draining
abscesses (Fig. 2 A, B) or subcutaneous abscesses at the knee and
hip joints (Fig. 2 C). No control groups (I and III) showed any sign
of infection. None of the animals was lost due to infection during
the 4 weeks of observation.
Infection in the NOD/ShiLtJ mice (group IV) was associated
with a marked and persistent loss in body weight by day 7 post-
infection as compared to their respective controls (group III).
Group II showed a similar loss in body weight at 7 days after
implantation, but they recovered quicker than the NOD/ShiLtJ
mice and a continued to regain weight (Fig. 3). The histogram in
Fig. 3 reports the percentage changes in body weight versus
baseline (day of inoculation/implantation).
Blood analysis
Basal total WBC was higher in the NOD/ShiLtJ mice than in
the CD1 mice in either control group (I and III). After 28 days
from surgery, the increase in total WBC count was higher in group
IV than in group III. In particular, group IV had higher WBC
Figure 2. Gross appearance at explantation. Draining abscess in the knee joint (A) and the hip joint (B), involving the subcutaneous tissue in the
mice in group IV (C).
doi:10.1371/journal.pone.0067628.g002
Figure 3. Relative changes in body weight. The histogram shows
the relative changes in body weight in the experimental groups over
time. A significant weight loss was noted in both groups II and IV versus
their controls at 7 days after surgery. Group II recovers body weight
starting from the second week after surgery. Differently, group IV
regained body weight slowly. Comparisons between groups and time
points were analyzed with two-way ANOVA, and Bonferroni’s post-hoc.
Statistical significance for P,0.001 (***), ,0.01 (**), ,0.05 (*); n = 8.
doi:10.1371/journal.pone.0067628.g003
Figure 4. Relative increase in total WBC. On day 28, relative
increases in WBC were significantly higher in group IV than in the other
groups (P,0.01**; n = 8). Comparisons between groups were analyzed
with one-way ANOVA, and Bonferroni’s post-hoc.
doi:10.1371/journal.pone.0067628.g004
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counts as compared to their respective controls (group III) and
groups I and II (Fig. 4).
The serum CRP levels, both at the day of surgery (D0) and after
28 days, remained very low (1.2460.06 mg/mL).
Micro-CT imaging analysis
Micro-CT examination confirmed that the pin was in place in
all the animals (Fig. 5).
On micro-CT analysis, the controls (groups I and III) and the
infected CD1 mice (group II) showed bone integrity and
topography in cortical or endosteal bone (Fig. 5 A, B, C). In
group IV, S. aureus produced extensive bone loss along the femoral
metaphysis, disruption of cortical integrity, and bone remodeling
with cortical thinning and canal widening (Fig. 5 D, E, F). In
addition, signs of septic arthritis were present with disruption of
cartilage and subchondral bone within the knee joint (Fig. 5 E).
The change in BMD for each group was analyzed by
normalizing each value to that of the intact femur of a healthy
CD1 mouse (1818.96 mg/cc). A decrease in BMD was noted in
the infected NOD/ShiLtJ mice (group IV) as compared to group I,
as shown in the histogram of Fig. 5.
Histological analysis of bones and joints
To determine the location of inflammatory infiltrate and
bacterial inoculum within the infected bones and joints, histolog-
ical sections of tissues harvested from the S. aureus-inoculated
(group II and IV) and the sham-inoculated control mice (group I
and III) at 28 days were examined.
The samples obtained from groups I, III and II showed no or
mild presence of inflammatory cells in the medullary canal which
contained normally erythroid, and myeloid cells. No bone
resorption or periosteal reactions were found in these samples
(Fig. 6).
In contrast, Gram-positive bacteria aggregates were detected in
the medullary canal of the infected NOD/ShiLtJ mice (group IV)
(Fig. 7 E), associated with a marked neutrophil infiltration and
micro- and macro-abscesses in the medullary canal and within the
joint capsule in the knee or hip joints (Fig. 7 A). New bone
formation and endosseous cortical bone resorption by osteoclasts
accompanied by enlargement of the medullary canal were
interpreted as signs of osteomyelitis. In group IV, polymorpho-
nucleated leukocytes and other inflammatory cells were present
(Fig. 7 B), as were severe periosteal reaction and fibrosis (Fig. 7 C)
and inguinal lymph node enlargement (Fig. 7 D). Table 3 reports
the histological scores of the four groups.
Microbiological analysis
Microbiological analysis confirmed the histological findings.
After sonication, no bacterial growth was observed either in
control groups (I and III) or in group II. In contrast, great amounts
of S. aureus were recovered from the samples collected from group
IV (mean 5.161.5 (Log CFU)/g bone) (Fig. 8).
Scanning electron microscopy
To determine whether biofilm formed on the implants in our
mouse model, one implant per group was harvested at day 28 (Fig.
9 – 10). Microbial biofilm formation was examined under SEM
after dehydrating and sputter-coating the samples with a
conductive film.
No detectable biofilm formation or bacterial aggregates were
visualized on the cut end of the implants within the knee joint both
in control groups (group I and III) (Fig. 9 A, B) and in group II
(Fig. 9 D). Similarly, no biofilm deposition was present along the
implant length within the femoral canal neither in the control
groups (Fig. 9 C) nor in group II (Fig. 9 E,F).
Only the samples from the infected NOD/ShiLtJ mice (group
IV) showed prominent biofilm growth around and on the cut end
of the implants (Fig. 10 A, B) and along the implant length fixed
within the femoral canal (Fig. 10 C, D).
Discussion
To our knowledge, this is the first description of an animal
model of orthopaedic implant-related infection in diabetes.
Postsurgical infection after prosthetic surgery is a severe
complication that often requires additional surgery and prolonged
antibiotic treatments, with diminished quality of life and added
costs. Bacterial adherence to foreign implanted materials and
subsequent microbial biofilm formation are distinctive character-
istics of implant-associated infections [1,27]. Treatment of these
infections poses medical and surgical challenges with a higher risk
of morbidity and poor clinical outcome [5,28,29]. When left
untreated, serious infections can progress to osteomyelitis and
bone destruction [30].
Although the type of casual microorganism and its antibiotic
resistance are critically important in the treatment and the
prognosis of septic complications in orthopaedics [31], host type
Figure 5. Representative micro-CT images and bone mineral density (BMD). Representative maximal intensity projection micro-CT images
of the femurs with the pin implants in transverse (A, D) and sagittal (B, C, E, F) views in group I (upper panel) and group IV (lower panel). The upper
panel shows the intact cortical bone profile without signs of infection (A), of the knee joint (B) and of the middle diaphysis section (C) in group I. The
lower panel shows extensive bone loss, disruption of cortical integrity, cortical thinning and canal widening (D), acute septic arthritis of the knee joint
(E) and bone loss in the middle diaphysis section (F) suggesting signs of established infection in group IV. The histogram shows a statistically
significant difference in the BMD of group IV, as analyzed with one-way ANOVA and Bonferroni’s post-hoc (*P,0.05; n = 5).
doi:10.1371/journal.pone.0067628.g005
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is probably even more important as a predictive factor of implant-
related infection and the relative chance of clearing it [32,33]. S.
aureus ATCC 25923, a common clinical isolate strain, can produce
biofilm in vitro [25]. This strain has also been described to
reproduce the periprosthetic infections in many animal models
[1,34,35].
In this regard, diabetes, because of its increasing prevalence
worldwide, is emerging as prominent risk factor of staphylococcal
infections and implant-related infection in orthopaedics [9,10].
To investigate host response to infection and ensuing compli-
cations in diabetics as compared to healthy patients, and with a
view to eventually employ our model to compare pharmacological
and surgical strategies for infection control in orthopaedics, we
developed an implant-related S. aureus infection model in the non-
obese diabetic mouse (NOD/ShiLtJ) in which we compared the
host response to identically infected healthy animals, CD1 mice in
this model. The NOD/ShiLtJ mouse provides a good model
because it spontaneously develops autoimmune diabetes and
exhibits immunological and clinical similarities to type I diabetes
in humans [10,36]. The diabetic mouse model of implant-related
bacterial infection has unique features that offer a valid option to
study the effect of diabetes on nosocomial infections comparable to
that any other laboratory animal could satisfy, except perhaps for
Figure 6. Histology of the femur in groups I and III and in group II. H&E staining of longitudinal sections of femurs. Note the absence of
inflammatory cells in the medullary canal, bone resorption and periosteal reaction in group I (A, B), group III (C, D), and group II (E, F) 28 days after
surgery. Left panel magnification 4X (scale bars 0.5 mm); right panel magnification 10X (scale bars 0.2 mm).
doi:10.1371/journal.pone.0067628.g006
Table 3. Histological scores (n = 3).
Group Sample Periosteum Cortex Medullary canal
I A 0 0 1
B 0 0 1
C 0 0 0
II A 1 1 1
B 1 1 1
C 1 0 1
III A 0 0 1
B 1 1 1
C 0 0 0
IV A 3 3 3
B 3 3 3
C 2 2 3
Groups I and III showed no histological signs of bone infection; group II showed
a mild inflammatory reaction and group IV showed a severe osteomyelitis in all
cases.
doi:10.1371/journal.pone.0067628.t003
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the diabetic rat [37]. Our model can also be successfully employed
to evaluate bacterial load and bone response in infected limbs, as
previously described in non-diabetic mice [22,24,27,38]. In
addition, permits evaluation of infection-induced osteomyelitis
through the direct measurement of the host response in infected
animal bones by combining the use of imaging techniques with
clinical, microbiological and histological analyses, which con-
firmed the validity of this animal model.
In the present study, the changes in body weight correlated with
induction and response to infection. The weight loss in the infected
CD1 mice during the early stage of infection (7 days post-
inoculation) could be closely related to the time required for
immune cell activation and for mounting activity against bacteria.
In fact, 7 days post inoculation, the CD1 mice were able to fight
against infection and regain their body weight, as previously
reported for C57BL/6J mice [39]. Differently, however, the
diabetic mice were unable to clear the infection over time and
continued to lose weight or regained it very slowly. This
phenomenon is linked to defects in the bactericidal activity of
polymorphonucleated cells in type 1 diabetic individuals, as
reported elsewhere [10,40–42] and to the direct inhibitory effect
Figure 7. Histology of the femur and lymph node in group IV. H&E staining showing inflammatory cells and micro abscesses in the medullary
canal (A, 2X, scale bar 1 mm); sequestrum formation (*) and fistula (black arrow) in the cortical bone (B, 4X, scale bar 0.5 mm); endosteal bone
resorption, several osteoclasts (red arrow), and marked periosteal reaction (**) (C, 20X, scale bar 0.1 mm). A lymph node reaction is shown in image D
(2X, scale bar 1 mm). Image E (2X, scale bar 1 mm) showing Gram-positive staining of bacterial clusters within a macroabscess of the knee joint
capsule (left small box, 40X, scale bar 0.05 mm) and within a microabscess in the medullary canal (right small box, 40X, scale bar 0.05 mm).
doi:10.1371/journal.pone.0067628.g007
Figure 8. Bacterial load in bones of all experimental groups.
The histogram compares the bacterial counts in the infected and
control mice. After inoculation with an infecting dose of 16103 CFU/
mouse, no colonies were detected in groups I, II and III. In contrast, a
mean of 5.161.5 (Log CFU)/g of bone in the femoral canal was found in
group IV (L.o.D. = limit of detection), which was statistically different
from the other groups, as analyzed with one-way ANOVA and
Bonferroni’s post-hoc (***P,0.0001; n = 4).
doi:10.1371/journal.pone.0067628.g008
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on the adaptive immune system which decreases proliferative
response and delays the hypersensitivity reaction of T-cell function
in diabetic patients [43–44].
Moreover, the higher basal WBC values observed in the
diabetic mice has also been reported in obese patients and in
patients with impaired glucose tolerance [45], in whom the
increased WBC count is thought to be responsible for macro- and
microvascular complications [46]. The relative increase in total
WBC count in the infected diabetic mice (group IV) was higher
than in the other experimental groups 4 weeks post inoculation,
suggesting that the infection due to S. aureus was maintained during
the chronic phase, as also demonstrated by Pettersson et al. [47].
CRP, a well-known acute phase protein in humans and
frequently used as a sensitive diagnostic marker for inflammatory
response, was analyzed 28 days after surgery. All serum levels
obtained in our study are underestimated, precluding comparison
with serum CRP values in humans. In humans, serum CRP
concentrations generally increase from ,1 mg/ml up to 500 mg/
ml during inflammation, whereas, in mice, serum CRP is ,2 mg/
ml, as found in our study (mean ,2 mg/ml), and does not usually
increase during the acute phase response [48]. Furthermore, the
normal CRP concentration in mouse serum has not yet been
established [48].
Typically, periosteal thickening and elevation are the earliest
radiographic signs of osteomyelitis in humans and are followed by
osteolytic changes related to subacute or chronic osteomyelitis
[49]. In the present study, micro-CT showed distinct changes
within the bone structure due to the infection in the S. aureus-
inoculated diabetic mice, confirming the development of chronic
osteomyelitis.
Histopathological determinations confirmed these results show-
ing more pronounced signs of infection in the infected diabetic
mice (group IV) as compared to the other groups. Histopatholog-
ical signs of infection were present in all diabetic mice with a
positive bacterial culture. As expected, in the uninfected groups (I
and III) but, unexpectedly, also in group II, signs of infection were
absent. Our findings are in line with those of other studies, which
attributed cortical bone resorption by osteoclasts, medullary canal
microabscesses and periosteal fibroblast proliferation during the
inflammatory chronic phase to activation of polymorphonucleated
cells [10,38,50].
These histological findings corroborate our imaging data,
demonstrating inflammatory cell infiltration and bacteria in both
Figure 9. Representative images of absence of biofilm deposition within the implant site in groups I, II and III by Scanning electron
microscopy (SEM) analysis. Absence of biofilm formation or bacterial deposition both on the cut ends of the implants (*) within the intercondylar
notches in the control groups, precisely in group I (A, scale bar 200 mm, small box 20 mm) and group III (B, scale bar 200 mm, small box 100 mm), and
along the implant length within the femoral canal (**) (C, scale bar 100 mm, small box 100 mm). Similarly, the absence of biofilm is shown in group II
on the cut ends of the implants (*) (D, scale bar 100 mm, small boxes 20 mm) and along the implant length (**) (E, scale bar 1 mm; F, scale bar 200 mm,
small box 100 mm).
doi:10.1371/journal.pone.0067628.g009
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the knee joint and the bone near the implant in group IV in
particular. Although inflammatory cells were abundant at the
prosthetic implant site, defects in the bactericidal activity of the
immune system, as reported in diabetic patients, may explain the
poor reaction toward S. aureus infection in the diabetic mice
[51,52].
The clinical, histological and imaging analyses of signs of
infection, and positive culture in agar plating of the sonicated
bones and tissues from group IV demonstrated the accuracy of our
diabetic model.
Interestingly, all the samples harvested from the infected
diabetic mice at 4 weeks post inoculation showed microbial
biofilm formation, as detected on SEM analysis. SEM visualized
the bacteria embedded in fibrotic tissue and biofilm growth on the
implants after sputter-coating with a conductive film. These data,
in spite of the limit related to the evaluation of a single sample per
group, confirm that the model may be used to study biofilm
formation in chronic post-arthroplasty infections [5,29].
Finally, the microbiological analyses revealed marked bacterial
growth in the diabetic mice, infected with an inoculum of S. aureus
identical to that of the healthy CD1 mice [24], which recovered
completely from the induced low-grade infection.
Our model is designed to approximate the clinical approach in
which uncoated implants and ceftriaxone administered by a one-
shot systemic injection are commonly used in the prophylaxis of
orthopaedic infection [53,54]. However, one limitation of the
model is that no other antibiotics, posology or local injections were
tested to compare reactions between the healthy and the diabetic
mice, as instead other studies in non-diabetic laboratory animals
have done [55–57]. And though overall successful, the results were
obtained in a limited number of animals. Furthermore, in spite of
the small size of mouse bones, we obtained excellent results with a
25G needle as a prosthetic implant, which will need to be verified
with commonly used implant metals such as titanium or steel alloy.
The differences regarding the genetic background between CD1
and NOD/ShiLtJ mice could affect their response to infection and
could represent a limitation to this study, although, the use of CD1
mice as control for NOD/ShiLtJ is currently reported in many
studies on diabetes [58–60]. Nevertheless, taken together, our data
demonstrate the validity of our animal model for orthopaedic
infections and osteomyelitis caused by bacteria commonly
responsible for infections in diabetic patients.
Conclusions
This original diabetic mouse model of orthopaedic implant-
infection shows the different susceptibility of diabetic mice to local
peri-prosthetic infection as compared to healthy individuals. The
model offers a new, relatively inexpensive tool to investigate in vivo
host response to different treatment options in diabetic and non-
diabetic subjects. It also provides an opportunity to further study
microbial biofilm formation in implant-related infections in
diabetes.
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